InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
8
T+90 hit rate
36%
T+90 mean return
-6.2%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Ajer Jeffrey Robert, Directeur et Directeur Exécutif Commercial. Officer active across 2 companies, notably NEKTAR THERAPEUTICS. In total, 24 filings have been published. Breakdown: 0 buy · 8 sells. Total volume traded: €1.2m. Activity tracked since 22 September 2021. The latest transaction was filed on 30 April 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations24 total
◆
300 shares@ US$68.6460.3% of flowCommon StockSEC:0001048477-24-000073:0
22,580 shares@ US$83.8726.3% of flowCommon StockSEC:0001048477-24-000036:0
▼
4,000 shares@ US$87.074.9% of flowCommon StockSEC:0001048477-24-000030:0
21,440 shares0Common StockSEC:0001048477-24-000022:0
4,359 shares@ US$0.6917.3% of flowCommon StockSEC:0001209191-23-050220:0
◆
318 shares@ US$66.8780.3% of flowCommon StockSEC:0001048477-23-000039:0
10,110 shares0Common StockSEC:0001567619-23-005283:0
20,760 shares0Common StockSEC:0001209191-23-014609:0
49,000 shares@ US$67.8146.2% of flowCommon StockSEC:0001567619-23-001396:0
▼
3,000 shares@ US$86.124.0% of flowCommon StockSEC:0001567619-22-019207:0
4,198 shares@ US$3.1682.7% of flowCommon StockSEC:0001209191-22-051304:0
10,200 shares0Common StockSEC:0001209191-22-050808:0
▼
3,000 shares@ US$95.624.2% of flowCommon StockSEC:0001567619-22-015887:0
●
7,021 shares@ US$77.490.0044% mcap55.1% of flowCommon StockSEC:0001567619-22-012432:0
◆
340 shares@ US$62.4070.0002% mcap2.2% of flowCommon StockSEC:0001567619-22-011966:0
▼
1,180 shares@ US$82.470.0008% mcap9.7% of flowCommon StockSEC:0001567619-22-008576:0
▼
1,618 shares@ US$79.430.0010% mcap12.6% of flowCommon StockSEC:0001567619-22-007808:0
▼
2,073 shares@ US$81.000.0013% mcap16.6% of flowCommon StockSEC:0001567619-22-007460:0
11,940 shares0Common StockSEC:0001567619-22-007177:0
9,370 shares0Common StockSEC:0001567619-22-006713:0
◆
342 shares@ US$62.4070.0002% mcap1.9% of flowCommon StockSEC:0001567619-21-018936:0
◆
342 shares@ US$62.4070.3% of flowCommon StockSEC:0001567619-21-018936
10,200 shares0Common StockSEC:0001209191-21-057702:0
10,200 shares0Common StockSEC:0001209191-21-057702
24 of 24 declarations
About Ajer Jeffrey Robert
Jeffrey Robert Ajer serves as Director and EVP, Chief Commercial Officer at Nektar Therapeutics and Biomarin Pharmaceutical Inc. He is responsible for commercial strategy and business development, contributing to the growth of both companies in the biopharmaceutical sector.
